137 related articles for article (PubMed ID: 10154611)
1. Cost-effective care.
Greener M
Health Serv J; 1995 Dec; 105(5483):suppl 5 p.. PubMed ID: 10154611
[No Abstract] [Full Text] [Related]
2. Unintended consequences of applying economic evaluation.
Oliver A
J Health Serv Res Policy; 2002 Jul; 7(3):129-30. PubMed ID: 12171741
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness considerations at NICE.
Rawlins M; Dillon A
Lancet; 2008 Oct; 372(9646):1302. PubMed ID: 18929903
[No Abstract] [Full Text] [Related]
4. Should NICE's threshold range for cost per QALY be raised? No.
Raftery J
BMJ; 2009 Jan; 338():b185. PubMed ID: 19171562
[No Abstract] [Full Text] [Related]
5. Should NICE's threshold range for cost per QALY be raised? Yes.
Towse A
BMJ; 2009 Jan; 338():b181. PubMed ID: 19171561
[No Abstract] [Full Text] [Related]
6. Finding a way through the cost and benefit maze.
Szczepura A
BMJ; 1994 Nov; 309(6965):1314-5. PubMed ID: 7866071
[No Abstract] [Full Text] [Related]
7. Need for differential discounting of costs and health effects in cost effectiveness analyses.
Brouwer WB; Niessen LW; Postma MJ; Rutten FF
BMJ; 2005 Aug; 331(7514):446-8. PubMed ID: 16110075
[TBL] [Abstract][Full Text] [Related]
8. How should we value future health? Was NICE right to change?
Raftery J
Value Health; 2013; 16(5):699-700. PubMed ID: 23947961
[No Abstract] [Full Text] [Related]
9. Reflections: NICE, health economics, and outcomes research.
Rawlins M
Value Health; 2012 May; 15(3):568-9. PubMed ID: 22583468
[No Abstract] [Full Text] [Related]
10. Cochrane Lecture. All cost effective treatments should be free ... or, how Archie Cochrane changed my life!
Williams A
J Epidemiol Community Health; 1997 Apr; 51(2):116-20. PubMed ID: 9196637
[No Abstract] [Full Text] [Related]
11. Is economic evaluation in touch with society's health values?
Coast J
BMJ; 2004 Nov; 329(7476):1233-6. PubMed ID: 15550430
[TBL] [Abstract][Full Text] [Related]
12. Crossing the line: NICE's value for money threshold.
Appleby J
BMJ; 2016 Mar; 352():i1336. PubMed ID: 26960807
[No Abstract] [Full Text] [Related]
13. Handling uncertainty in economic evaluations of healthcare interventions.
Briggs AH; Gray AM
BMJ; 1999 Sep; 319(7210):635-8. PubMed ID: 10473486
[No Abstract] [Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation.
Clegg AJ; Colquitt J; Sidhu MK; Royle P; Loveman E; Walker A
Health Technol Assess; 2002; 6(12):1-153. PubMed ID: 12196283
[No Abstract] [Full Text] [Related]
15. The DH register of cost-effectiveness studies: content and quality.
Mason J; Drummond M
Health Trends; 1995; 27(2):50-6. PubMed ID: 10153159
[TBL] [Abstract][Full Text] [Related]
16. R&D. Failing the acid test.
Millar B
Health Serv J; 1998 Mar; 108(5597):24-7. PubMed ID: 10177609
[No Abstract] [Full Text] [Related]
17. Cost effectiveness of complementary treatments in the United Kingdom: systematic review.
Canter PH; Coon JT; Ernst E
BMJ; 2005 Oct; 331(7521):880-1. PubMed ID: 16223821
[No Abstract] [Full Text] [Related]
18. Distribution of health care costs and their statistical analysis for economic evaluation (Vol 3 No 4 pp 233-245).
Thompson S; Barber J
J Health Serv Res Policy; 1999 Oct; 4(4):255-6. PubMed ID: 10623043
[No Abstract] [Full Text] [Related]
19. Practical thoughts on cost-benefit analysis and health services.
Burchell A; Weeden R
Health Trends; 1982 Aug; 14(3):56-60. PubMed ID: 10309840
[TBL] [Abstract][Full Text] [Related]
20. An open letter to the health secretary: how to really save money on the NHS.
Lachmann P
BMJ; 2010 Oct; 341():c5618. PubMed ID: 20947579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
